CA2388198A1 - Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations - Google Patents

Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations Download PDF

Info

Publication number: CA2388198A1
Authority: CA; Canada
Prior art keywords: adrenocorticotropic hormone; hormone receptor; mammalian; human; receptor
Prior art date: 1992-04-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002388198A

Other languages

English (en)

Inventor

Roger D. Cone

Kathleen G. Mountjoy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oregon Health and Science University

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-10

Filing date

1993-04-07

Publication date

1993-10-28

1992-04-10 Priority claimed from US07/866,560 external-priority patent/US5280112A/en

1993-04-07 Application filed by Individual filed Critical Individual

1993-10-28 Publication of CA2388198A1 publication Critical patent/CA2388198A1/fr

Status Abandoned legal-status Critical Current

Links

108010074311 Corticotropin Receptors Proteins 0.000 title claims abstract description 37
102000008064 Corticotropin Receptors Human genes 0.000 title claims abstract description 36
101800000414 Corticotropin Proteins 0.000 claims abstract description 50
229960000258 corticotropin Drugs 0.000 claims abstract description 48
239000000275 Adrenocorticotropic Hormone Substances 0.000 claims abstract description 46
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims abstract description 45
241000282414 Homo sapiens Species 0.000 claims abstract description 42
238000000034 method Methods 0.000 claims abstract description 33
108020003175 receptors Proteins 0.000 claims abstract description 26
230000014509 gene expression Effects 0.000 claims abstract description 24
210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 23
101000678424 Bos taurus Adrenocorticotropic hormone receptor Proteins 0.000 claims abstract description 11
238000002955 isolation Methods 0.000 claims abstract description 10
239000000556 agonist Substances 0.000 claims abstract description 8
238000012512 characterization method Methods 0.000 claims abstract description 8
238000012216 screening Methods 0.000 claims abstract description 5
102100027467 Pro-opiomelanocortin Human genes 0.000 claims abstract 6
210000004027 cell Anatomy 0.000 claims description 53
239000002773 nucleotide Substances 0.000 claims description 39
125000003729 nucleotide group Chemical group 0.000 claims description 39
239000000523 sample Substances 0.000 claims description 33
101000678419 Homo sapiens Adrenocorticotropic hormone receptor Proteins 0.000 claims description 27
238000003259 recombinant expression Methods 0.000 claims description 17
101500024073 Bos taurus Corticotropin Proteins 0.000 claims description 15
230000027455 binding Effects 0.000 claims description 14
238000007899 nucleic acid hybridization Methods 0.000 claims description 14
239000000203 mixture Substances 0.000 claims description 13
238000004113 cell culture Methods 0.000 claims description 12
239000012634 fragment Substances 0.000 claims description 12
108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
150000001875 compounds Chemical class 0.000 claims description 11
108020004707 nucleic acids Proteins 0.000 claims description 10
102000039446 nucleic acids Human genes 0.000 claims description 10
150000007523 nucleic acids Chemical class 0.000 claims description 10
238000001514 detection method Methods 0.000 claims description 8
150000001413 amino acids Chemical group 0.000 claims description 7
230000004071 biological effect Effects 0.000 claims description 4
210000004369 blood Anatomy 0.000 claims description 3
239000008280 blood Substances 0.000 claims description 3
239000003112 inhibitor Substances 0.000 claims description 3
230000001131 transforming effect Effects 0.000 claims description 3
208000026350 Inborn Genetic disease Diseases 0.000 claims description 2
201000010099 disease Diseases 0.000 claims description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
208000016361 genetic disease Diseases 0.000 claims description 2
238000003745 diagnosis Methods 0.000 claims 2
229940044601 receptor agonist Drugs 0.000 claims 2
239000000018 receptor agonist Substances 0.000 claims 2
210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
230000010807 negative regulation of binding Effects 0.000 claims 1
239000008194 pharmaceutical composition Substances 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 abstract description 31
102000005962 receptors Human genes 0.000 abstract description 22
101500024079 Homo sapiens Corticotropin Proteins 0.000 abstract description 21
239000005557 antagonist Substances 0.000 abstract description 10
238000002360 preparation method Methods 0.000 abstract description 7
108091008039 hormone receptors Proteins 0.000 abstract description 5
238000000338 in vitro Methods 0.000 abstract description 4
230000000144 pharmacologic effect Effects 0.000 abstract description 3
239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract 2
241000283690 Bos taurus Species 0.000 description 39
102400000739 Corticotropin Human genes 0.000 description 39
108020004414 DNA Proteins 0.000 description 21
210000001519 tissue Anatomy 0.000 description 19
239000003795 chemical substances by application Substances 0.000 description 17
239000002299 complementary DNA Substances 0.000 description 13
235000018102 proteins Nutrition 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
102100022455 Adrenocorticotropic hormone receptor Human genes 0.000 description 10
108090000765 processed proteins & peptides Proteins 0.000 description 10
239000013598 vector Substances 0.000 description 10
125000003275 alpha amino acid group Chemical group 0.000 description 9
229940079593 drug Drugs 0.000 description 9
239000003814 drug Substances 0.000 description 9
238000009396 hybridization Methods 0.000 description 9
108020004999 messenger RNA Proteins 0.000 description 9
239000000047 product Substances 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
241001465754 Metazoa Species 0.000 description 7
206010035226 Plasma cell myeloma Diseases 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
210000004379 membrane Anatomy 0.000 description 7
239000012528 membrane Substances 0.000 description 7
201000000050 myeloid neoplasm Diseases 0.000 description 7
241000894007 species Species 0.000 description 7
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
102000004196 processed proteins & peptides Human genes 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
108091006027 G proteins Proteins 0.000 description 5
102000030782 GTP binding Human genes 0.000 description 5
108091000058 GTP-Binding Proteins 0.000 description 5
241000699670 Mus sp. Species 0.000 description 5
230000001919 adrenal effect Effects 0.000 description 5
235000001014 amino acid Nutrition 0.000 description 5
238000010367 cloning Methods 0.000 description 5
238000009826 distribution Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000010353 genetic engineering Methods 0.000 description 5
229940088597 hormone Drugs 0.000 description 5
239000005556 hormone Substances 0.000 description 5
210000004408 hybridoma Anatomy 0.000 description 5
108091026890 Coding region Proteins 0.000 description 4
108010000410 MSH receptor Proteins 0.000 description 4
241000282560 Macaca mulatta Species 0.000 description 4
238000012408 PCR amplification Methods 0.000 description 4
241000700159 Rattus Species 0.000 description 4
239000002775 capsule Substances 0.000 description 4
239000012530 fluid Substances 0.000 description 4
238000011534 incubation Methods 0.000 description 4
230000003834 intracellular effect Effects 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
201000001441 melanoma Diseases 0.000 description 4
238000001000 micrograph Methods 0.000 description 4
230000010076 replication Effects 0.000 description 4
239000000243 solution Substances 0.000 description 4
241000699800 Cricetinae Species 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 3
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 3
101000975753 Homo sapiens Acid ceramidase Proteins 0.000 description 3
108090000950 Melanocortin Receptors Proteins 0.000 description 3
102000004378 Melanocortin Receptors Human genes 0.000 description 3
241001529936 Murinae Species 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
210000004100 adrenal gland Anatomy 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
238000007901 in situ hybridization Methods 0.000 description 3
238000011081 inoculation Methods 0.000 description 3
108091027963 non-coding RNA Proteins 0.000 description 3
102000042567 non-coding RNA Human genes 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
239000013615 primer Substances 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
241001514645 Agonis Species 0.000 description 2
206010003445 Ascites Diseases 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 2
101000903587 Homo sapiens Cytosolic acyl coenzyme A thioester hydrolase Proteins 0.000 description 2
101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
101000624978 Mus musculus Melanocyte-stimulating hormone receptor Proteins 0.000 description 2
238000000636 Northern blotting Methods 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
241000288906 Primates Species 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
241000700605 Viruses Species 0.000 description 2
101001100790 Xenopus laevis Protein quaking-A Proteins 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
210000004404 adrenal cortex Anatomy 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
230000004927 fusion Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
239000003446 ligand Substances 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
230000006337 proteolytic cleavage Effects 0.000 description 2
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
210000004989 spleen cell Anatomy 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
210000001235 zona fasciculata Anatomy 0.000 description 2
210000003368 zona glomerulosa Anatomy 0.000 description 2
HEAUFJZALFKPBA-JPQUDPSNSA-N (3s)-3-[[(2s,3r)-2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 HEAUFJZALFKPBA-JPQUDPSNSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
102000013585 Bombesin Human genes 0.000 description 1
108010051479 Bombesin Proteins 0.000 description 1
101000975812 Bos taurus Acid ceramidase Proteins 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
102000018208 Cannabinoid Receptor Human genes 0.000 description 1
108050007331 Cannabinoid receptor Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
235000004863 Fevillea cordifolia Nutrition 0.000 description 1
244000034902 Fevillea cordifolia Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
101100346560 Homo sapiens MC1R gene Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108010008364 Melanocortins Proteins 0.000 description 1
101100534475 Mus musculus Stambp gene Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
102400000097 Neurokinin A Human genes 0.000 description 1
101800000399 Neurokinin A Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
241000277269 Oncorhynchus masou Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
229920002534 Polyethylene Glycol 1450 Polymers 0.000 description 1
108020005067 RNA Splice Sites Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241001274197 Scatophagus argus Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
201000007073 Triple A syndrome Diseases 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
230000001780 adrenocortical effect Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
229960002478 aldosterone Drugs 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
238000003556 assay Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000000133 brain stem Anatomy 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
229930003827 cannabinoid Natural products 0.000 description 1
239000003557 cannabinoid Substances 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
230000037029 cross reaction Effects 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000029087 digestion Effects 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000007877 drug screening Methods 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000010437 gem Substances 0.000 description 1
238000012239 gene modification Methods 0.000 description 1
230000005017 genetic modification Effects 0.000 description 1
235000013617 genetically modified food Nutrition 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
230000036541 health Effects 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
102000054812 human MC1R Human genes 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
230000004807 localization Effects 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000010445 mica Substances 0.000 description 1
229910052618 mica group Inorganic materials 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
102000014187 peptide receptors Human genes 0.000 description 1
108010011903 peptide receptors Proteins 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
230000037452 priming Effects 0.000 description 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
239000003379 purinergic P1 receptor agonist Substances 0.000 description 1
239000000296 purinergic P1 receptor antagonist Substances 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000001525 receptor binding assay Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
101150033202 thr gene Proteins 0.000 description 1
238000011426 transformation method Methods 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA002388198A 1992-04-10 1993-04-07 Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations Abandoned CA2388198A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US866,560		1992-04-10
US07/866,560 US5280112A (en)	1992-04-10	1992-04-10	DNA sequence encoding bovine and human adrenocorticotropic hormone receptors
CA002133845A CA2133845C (fr)	1992-04-10	1993-04-07	Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002133845A Division CA2133845C (fr)	1992-04-10	1993-04-07	Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations

Publications (1)

Publication Number	Publication Date
CA2388198A1 true CA2388198A1 (fr)	1993-10-28

Family

ID=25677557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002388198A Abandoned CA2388198A1 (fr)	1992-04-10	1993-04-07	Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations

Country Status (1)

Country	Link
CA (1)	CA2388198A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2798903C1 (ru) *	2022-09-13	2023-06-28	Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России)	Способ определения адренокортикотропного гормона в экссудате "кожного окна"

1993
- 1993-04-07 CA CA002388198A patent/CA2388198A1/fr not_active Abandoned

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2798903C1 (ru) *	2022-09-13	2023-06-28	Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России)	Способ определения адренокортикотропного гормона в экссудате "кожного окна"

Legal Events

Date	Code	Title	Description
2002-06-26	EEER	Examination request
2007-12-03	FZDE	Dead

Publication	Publication Date	Title
EP0635054B1 (fr)	2003-11-26	Recepteurs d'hormone melanostimulante de mammiferes et utilisations
Lomasney et al.	1991	Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5.
Varona et al.	1998	Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3α
US5837521A (en)	1998-11-17	Nucleic acids encoding the γ-MSH receptor MC3-R
US20040216177A1 (en)	2004-10-28	Congenic rats containing a mutant GPR10 gene
JP3534406B2 (ja)	2004-06-07	免疫グロブリンＥの高アフィニティレセプタのヒトβサブユニットの分離，特性化および用法
EP0365657A4 (en)	1991-08-21	Dna encoding androgen receptor protein
CA2133845C (fr)	2002-07-09	Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations
US5658783A (en)	1997-08-19	Mammalian methadone-specific opioid receptor gene and uses
EP1208196B1 (fr)	2006-10-18	Nouvelle molecule 15571 de type gpcr de la famille secretine et utilisations de cette derniere
JPWO1999033978A1 (ja)	2002-09-24	新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタータンパク質
WO1999033978A1 (fr)	1999-07-08	Nouvelles proteines receptrices du type conjugue guanosine triphosphate (gtp)-proteine de liaison
JP2005229804A (ja)	2005-09-02	新規なメラニンコンセントレーティングホルモン受容体
CA2388198A1 (fr)	1993-10-28	Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations
AU718702B2 (en)	2000-04-20	Mammalian melanocyte stimulating hormone receptors and uses
AU2002325314B2 (en)	2008-07-10	Allelic variants of GPR50
TW200532019A (en)	2005-10-01	Nucleic acid encoding a novel DP receptor protein and methods of use thereof
Gurka et al.	2009	Generation of novel anti-BTLA monoclonal antibodies for in vivo use and their functional testing at Near-physiological conditions
AU2002325314A1 (en)	2003-05-22	Allelic variants of GPR50
USRE42190E1 (en)	2011-03-01	Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
DE69926650T2 (de)	2006-01-19	Menschliche, an ein g-protein gekoppelter rezeptor rup3 ohne beligand
US20030139589A1 (en)	2003-07-24	G protein coupled receptor A4
CA2284857A1 (fr)	2000-04-16	Recepteur a4 couple a une proteine g

CA2388198A1 - Recepteurs de l'hormone adrenocorticotrope chez les mammiferes et leurs utilisations - Google Patents

Info

Links

Landscapes

Applications Claiming Priority (3)

Related Parent Applications (1)

Publications (1)

Family

ID=25677557

Family Applications (1)

Country Status (1)

Cited By (1)

Cited By (1)

Similar Documents

Legal Events